A new nerve block strategy for shoulder surgery avoids a key respiratory complication
A recent randomized controlled trial published in Regional Anesthesia & Pain Medicine offers a significant advance in perioperative pain management for arthroscopic shoulder surgery, a common procedure often required for patients with inflammatory and degenerative joint diseases like rheumatoid arthritis and osteoarthritis. The study compared the traditional interscalene brachial plexus block (ISB), known to cause nearly universal hemidiaphragmatic paralysis, against a novel combined infraclavicular and anterior suprascapular nerve block (ICB-SSNB). Using ultrasound guidance, researchers administered local anesthetic to fifty patients. The results demonstrated that the combined ICB-SSNB provided equivalent postoperative analgesia at 30 minutes and over the following 48 hours, with comparable rates of complete sensorimotor blockade, opioid consumption, and patient satisfaction. Crucially, while the ISB group had an 88% incidence of hemidiaphragmatic paralysis in recovery, the incidence in the combined block group was zero.
Study Significance: For rheumatologists managing patients with chronic inflammatory arthritis who require recurrent joint surgeries, this development addresses a critical safety concern. The elimination of hemidiaphragmatic paralysis expands the pool of patients who can safely receive effective regional anesthesia, particularly benefiting those with pre-existing respiratory compromise. This research directly informs collaborative decision-making with surgical and anesthesiology teams, potentially shifting the standard of care for perioperative pain control in shoulder procedures to optimize both patient comfort and pulmonary safety.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
